AU2003240468A1 - Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2) - Google Patents

Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2)

Info

Publication number
AU2003240468A1
AU2003240468A1 AU2003240468A AU2003240468A AU2003240468A1 AU 2003240468 A1 AU2003240468 A1 AU 2003240468A1 AU 2003240468 A AU2003240468 A AU 2003240468A AU 2003240468 A AU2003240468 A AU 2003240468A AU 2003240468 A1 AU2003240468 A1 AU 2003240468A1
Authority
AU
Australia
Prior art keywords
therapeutics
diagnostics
diseases associated
neurotensin receptor
neurotensin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003240468A
Inventor
Ulf Bruggemeier
Stefan Golz
Holger Summer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003240468A1 publication Critical patent/AU2003240468A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003240468A 2002-05-02 2003-04-28 Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2) Abandoned AU2003240468A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02009313 2002-05-02
EP02009313.4 2002-05-02
PCT/EP2003/004399 WO2003093829A1 (en) 2002-05-02 2003-04-28 Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2)

Publications (1)

Publication Number Publication Date
AU2003240468A1 true AU2003240468A1 (en) 2003-11-17

Family

ID=29286098

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003240468A Abandoned AU2003240468A1 (en) 2002-05-02 2003-04-28 Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2)

Country Status (2)

Country Link
AU (1) AU2003240468A1 (en)
WO (1) WO2003093829A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2760750B1 (en) * 1997-03-17 1999-05-28 Sanofi Sa HUMAN NEUROTENSIN TYPE 2 RECEPTOR (HNT-R2)
US6008050A (en) * 1997-04-02 1999-12-28 Smithkline Beecham Corporation Human neurotensin receptor type 2 and splice variants thereof
US6420137B1 (en) * 1998-11-25 2002-07-16 American Home Products Corporation Nucleic acid encoding human neurotensin subtype 2 receptor
NZ521158A (en) * 2000-04-07 2004-08-27 Arena Pharm Inc Non-endogenous, constitutively activated known G protein-coupled receptors
IL142707A0 (en) * 2000-04-27 2002-03-10 Pfizer Prod Inc Methods of treating obesity using a neurotensin receptor ligand

Also Published As

Publication number Publication date
WO2003093829A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2003289716A1 (en) Molecules for diagnostics and therapeutics
AU2003214249A1 (en) Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
AU2003214072A1 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003210518A1 (en) Molecules for diagnostics and therapeutics
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003273994A1 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003240468A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2)
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003229753A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
AU2003216866A1 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003267443A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003279361A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
AU2003289894A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
AU2003301892A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)
AU2003245981A1 (en) Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase